文献速递急性肾损伤

术中最低红细胞压积改善心脏手术后急性肾损伤预测

Improving the Prediction of Cardiac Surgery-Associated Acute Kidney Injury.
PubMed 文献 · Kidney Int Rep · 2016-10-21

这项前瞻性队列研究纳入289例择期心脏手术患者,比较Cleveland Clinic评分(CCS)单独或联合术中变量预测术后急性肾损伤(AKI)的效能。结果显示,CCS单独预测AKI的AUC为0.72,加入术中最低红细胞压积后AUC提升至0.78(P=0.002)。在无慢性肾脏病的亚组中,CCS预测效能较低(AUC=0.60),联合最低红细胞压积后改善更明显(AUC=0.74)。

要点

  • 术中最低红细胞压积可提升CCS对心脏术后AKI的预测效能。
  • 在无慢性肾脏病患者中,联合最低红细胞压积的预测改善更显著。
  • 其他术中变量未改善CCS的预测区分度。

核心结论

  • 术中最低红细胞压积有助于改善临床风险评分对心脏手术后AKI的预测区分度。
  • 术中最低红细胞压积可能为干预提供靶点。

研究设计与样本

  • 前瞻性队列研究,纳入289例连续择期心脏手术患者,比较含或不含术中变量的模型预测术后AKI的AUC。
  • AKI定义采用KDIGO 2012标准。

主要发现

  • CCS单独预测术后AKI的AUC为0.72(95%CI 0.62-0.82)。
  • CCS联合术中最低红细胞压积后AUC为0.78(95%CI 0.70-0.87),P=0.002。
  • 在无慢性肾脏病亚组(n=214)中,CCS的AUC为0.60(95%CI 0.43-0.76),联合最低红细胞压积后AUC为0.74(95%CI 0.62-0.86)。
  • 其他术中变量(平均动脉压、手术时长、输血、液体平衡)未改善预测区分度。

临床怎么用

  • 在临床风险评分基础上,可考虑纳入术中最低红细胞压积以优化心脏手术后AKI风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Acute kidney injury (AKI) is a potentially fatal complication of cardiac surgery. The inability to predict cardiac surgery-associated AKI is a major barrier to prevention and early treatment. Current clinical risk models for the prediction of cardiac surgery-associated AKI are insufficient, particularly in patients with preexisting kidney dysfunction. METHODS: To identify intraoperative variables that might improve the performance of a validated clinical risk score (Cleveland Clinic Score, CCS) for the prediction of cardiac surgery-associated AKI, we conducted a prospective cohort study in 289 consecutive elective cardiac surgery patients at a tertiary care center. We compared the area under the receiver operator characteristic curve (AUC) of a base model including only the CCS with models containing additional selected intraoperative variables including mean arterial pressure, hematocrit, duration of procedure, blood transfusions, and fluid balance. AKI was defined by the Kidney Disease Improving Global Outcomes 2012 criteria. RESULTS: The CCS alone gave an AUC of 0.72 (95% confidence interval, 0.62-0.82) for postoperative AKI. Nadir intraoperative hematocrit was the only variable that improved AUC for postoperative AKI when added to the CCS (AUC = 0.78; 95% confidence interval, 0.70-0.87; P = 0.002). In the subcohort of patients without preexisting chronic kidney disease (n = 214), where the CCS underperformed (AUC, 0.60 [0.43-0.76]), the improvement with the addition of nadir hematocrit was more marked (AUC, 0.74 [0.62-0.86]). Other variables did not improve discrimination. DISCUSSION: Nadir intraoperative hematocrit is useful in improving discrimination of clinical risk scores for AKI, and may provide a target for intervention.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Crosina J, Lerner J, Ho J, et al. Improving the Prediction of Cardiac Surgery-Associated Acute Kidney Injury. Kidney Int Rep. 2016. PMID: 29142955. doi:10.1016/j.ekir.2016.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。